These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

544 related items for PubMed ID: 16405540

  • 1. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
    Brand S, Hofbauer K, Dambacher J, Schnitzler F, Staudinger T, Pfennig S, Seiderer J, Tillack C, Konrad A, Göke B, Ochsenkühn T, Lohse P.
    Am J Gastroenterol; 2006 Jan; 101(1):99-106. PubMed ID: 16405540
    [Abstract] [Full Text] [Related]

  • 2. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.
    Sabate JM, Ameziane N, Lamoril J, Jouet P, Farmachidi JP, Soulé JC, Harnois F, Sobhani I, Jian R, Deybach JC, de Prost D, Coffin B.
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):748-55. PubMed ID: 18617779
    [Abstract] [Full Text] [Related]

  • 3. Molecular stratification of Crohn's disease by chemokine receptors: fractalkine receptor polymorphisms define a fibrostenosing ileal subgroup.
    Binion DG, Kugathasan S, Dwinell MB.
    Am J Gastroenterol; 2006 Jan; 101(1):107-9. PubMed ID: 16405541
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expression of CX3C chemokine, fractalkine, and its receptor CX3CR1 in experimental autoimmune anterior uveitis.
    Fang IM, Lin CP, Yang CM, Chen MS, Yang CH.
    Mol Vis; 2005 Jul 01; 11():443-51. PubMed ID: 16030495
    [Abstract] [Full Text] [Related]

  • 6. T280M and V249I polymorphisms of fractalkine receptor CX3CR1 and ischemic cerebrovascular disease.
    Hattori H, Ito D, Tanahashi N, Murata M, Saito I, Watanabe K, Suzuki N.
    Neurosci Lett; 2005 Feb 10; 374(2):132-5. PubMed ID: 15644279
    [Abstract] [Full Text] [Related]

  • 7. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation.
    Echigo T, Hasegawa M, Shimada Y, Takehara K, Sato S.
    J Allergy Clin Immunol; 2004 May 10; 113(5):940-8. PubMed ID: 15131578
    [Abstract] [Full Text] [Related]

  • 8. Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation.
    Niessner A, Marculescu R, Haschemi A, Endler G, Zorn G, Weyand CM, Maurer G, Mannhalter C, Wojta J, Wagner O, Huber K.
    Thromb Haemost; 2005 May 10; 93(5):949-54. PubMed ID: 15886814
    [Abstract] [Full Text] [Related]

  • 9. Lack of association between the functional CX3CR1 polymorphism V249I and hepatocellular carcinoma.
    Mühlbauer M, Ringel S, Hartmann A, Lallinger G, Weiss TS, Gäbele E, Wünsch PH, Schölmerich J, Hellerbrand C.
    Oncol Rep; 2005 May 10; 13(5):957-63. PubMed ID: 15809764
    [Abstract] [Full Text] [Related]

  • 10. Proinflammatory role of fractalkine (CX3CL1) in rheumatoid arthritis.
    Blaschke S, Koziolek M, Schwarz A, Benöhr P, Middel P, Schwarz G, Hummel KM, Müller GA.
    J Rheumatol; 2003 Sep 10; 30(9):1918-27. PubMed ID: 12966591
    [Abstract] [Full Text] [Related]

  • 11. The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection.
    Wasmuth HE, Zaldivar MM, Berres ML, Werth A, Scholten D, Hillebrandt S, Tacke F, Schmitz P, Dahl E, Wiederholt T, Hellerbrand C, Berg T, Weiskirchen R, Trautwein C, Lammert F.
    J Hepatol; 2008 Feb 10; 48(2):208-15. PubMed ID: 18078680
    [Abstract] [Full Text] [Related]

  • 12. Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts.
    Isse K, Harada K, Zen Y, Kamihira T, Shimoda S, Harada M, Nakanuma Y.
    Hepatology; 2005 Mar 10; 41(3):506-16. PubMed ID: 15726664
    [Abstract] [Full Text] [Related]

  • 13. Association study between the CX3CR1 gene and asthma.
    Tremblay K, Lemire M, Provost V, Pastinen T, Renaud Y, Sandford AJ, Laviolette M, Hudson TJ, Laprise C.
    Genes Immun; 2006 Dec 10; 7(8):632-9. PubMed ID: 17082760
    [Abstract] [Full Text] [Related]

  • 14. Role of the fractalkine receptor CX3CR1 polymorphisms V249I and T280M as risk factors for early-onset coronary artery disease in patients with no classic risk factors.
    Nassar BA, Nanji AA, Ransom TP, Rockwood K, Kirkland SA, Macpherson K, Connelly PW, Johnstone DE, O'Neill BJ, Bata IR, Andreou P, Title LM.
    Scand J Clin Lab Invest; 2008 Dec 10; 68(4):286-91. PubMed ID: 18609106
    [Abstract] [Full Text] [Related]

  • 15. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis.
    Ruth JH, Volin MV, Haines GK, Woodruff DC, Katschke KJ, Woods JM, Park CC, Morel JC, Koch AE.
    Arthritis Rheum; 2001 Jul 10; 44(7):1568-81. PubMed ID: 11465708
    [Abstract] [Full Text] [Related]

  • 16. Polymorphism of the fractalkine receptor CX3CR1 and systemic sclerosis-associated pulmonary arterial hypertension.
    Marasini B, Cossutta R, Selmi C, Pozzi MR, Gardinali M, Massarotti M, Erario M, Battaglioli L, Biondi ML.
    Clin Dev Immunol; 2005 Dec 10; 12(4):275-9. PubMed ID: 16584113
    [Abstract] [Full Text] [Related]

  • 17. Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1).
    Lucas AD, Bursill C, Guzik TJ, Sadowski J, Channon KM, Greaves DR.
    Circulation; 2003 Nov 18; 108(20):2498-504. PubMed ID: 14581400
    [Abstract] [Full Text] [Related]

  • 18. Fractalkine-CX3CR1 axis regulates tumor cell cycle and deteriorates prognosis after radical resection for hepatocellular carcinoma.
    Matsubara T, Ono T, Yamanoi A, Tachibana M, Nagasue N.
    J Surg Oncol; 2007 Mar 01; 95(3):241-9. PubMed ID: 17323338
    [Abstract] [Full Text] [Related]

  • 19. Association of common polymorphisms in the fractalkine receptor (CX3CR1) with obesity.
    Sirois-Gagnon D, Chamberland A, Perron S, Brisson D, Gaudet D, Laprise C.
    Obesity (Silver Spring); 2011 Jan 01; 19(1):222-7. PubMed ID: 20523302
    [Abstract] [Full Text] [Related]

  • 20. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in periodontal diseased tissue.
    Hosokawa Y, Nakanishi T, Yamaguchi D, Nakae H, Matsuo T.
    Clin Exp Immunol; 2005 Mar 01; 139(3):506-12. PubMed ID: 15730397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.